
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DEC1 CRISPR/Cas9 KO Plasmid (m) | sc-423203 | 20 µg | $397.00 | |||
DEC1 HDR Plasmid (m) | sc-423203-HDR | 20 µg | $445.00 |
Bhlhe40 encodes the transcription factor DEC1 (also known as BHLHE40), a basic helix-loop-helix regulator that integrates environmental cues into gene expression programs controlling differentiation, proliferation, and cellular stress adaptation. In mouse systems, DEC1 participates in circadian and hypoxia-responsive networks and can modulate signaling nodes such as HIF-dependent transcriptional responses and pathways linked to inflammatory gene expression. By influencing cell-cycle regulators and metabolic remodeling, DEC1 has been studied in contexts including immune cell polarization, barrier tissues, and tumor biology. Dysregulated Bhlhe40/DEC1 activity has been associated with altered inflammatory responses and aberrant growth control, making it a useful target for mechanistic studies of transcriptional circuitry.
DEC1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Bhlhe40 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Bhlhe40 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, DEC1 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Bhlhe40 target site.
When co-transfected with DEC1 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Bhlhe40 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.